Structure of TOR and its complex with KOG1

被引:67
作者
Adami, Alessandra
Garcia-Alvarez, Begona
Arias-Palomo, Ernesto
Barford, David
Llorca, Oscar
机构
[1] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England
[2] CSIC, Ctr Invest Biol, Madrid 28040, Spain
关键词
D O I
10.1016/j.molcel.2007.05.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The target of rapamycin (TOR) is a large (281 kDa) conserved Ser/Thr protein kinase that functions as a central controller of cell growth. TOR assembles into two distinct multiprotein complexes: TORC1 and TORC2. A defining feature of TORC1 is the interaction of TOR with KOG1 (Raptor in mammals) and its sensitivity to a rapamycin-FKBP12 complex. Here, we have reconstructed in three dimensions the 25 A resolution structures of endogenous budding yeast TOR1 and a TOR-KOG1 complex, using electron microscopy. TOR features distinctive N-terminal HEAT repeats that form a curved tubular-shaped domain that associates with the C-terminal WD40 repeat domain of KOG1. The N terminus of KOG1 is in proximity to the TOR kinase domain, likely functioning to bring substrates into the vicinity of the catalytic region. A model is proposed for the molecular architecture of the TOR-KOG1 complex explaining its sensitivity to rapamycin.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 27 条
  • [1] CHOI JP, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8
  • [2] The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability
    Dames, SA
    Mulet, JM
    Rathgeb-Szabo, K
    Hall, MN
    Grzesiek, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (21) : 20558 - 20564
  • [3] ADP_EM:: fast exhaustive multi-resolution docking for high-throughput coverage
    Garzon, Jose Ignacio
    Kovacs, Julio
    Abagyan, Ruben
    Chacon, Pablo
    [J]. BIOINFORMATICS, 2007, 23 (04) : 427 - 433
  • [4] Topological characteristics of helical repeat proteins
    Groves, MR
    Barford, D
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 1999, 9 (03) : 383 - 389
  • [5] An expanding role for mTOR in cancer
    Guertin, DA
    Sabatini, DM
    [J]. TRENDS IN MOLECULAR MEDICINE, 2005, 11 (08) : 353 - 361
  • [6] Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
    Hara, K
    Maruki, Y
    Long, XM
    Yoshino, K
    Oshiro, N
    Hidayat, S
    Tokunaga, C
    Avruch, J
    Yonezawa, K
    [J]. CELL, 2002, 110 (02) : 177 - 189
  • [7] TARGETS FOR CELL-CYCLE ARREST BY THE IMMUNOSUPPRESSANT RAPAMYCIN IN YEAST
    HEITMAN, J
    MOVVA, NR
    HALL, MN
    [J]. SCIENCE, 1991, 253 (5022) : 905 - 909
  • [8] TUMOR-NECROSIS-FACTOR RECEPTOR-MEDIATED SIGNALING PATHWAYS
    HELLER, RA
    KRONKE, M
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 126 (01) : 5 - 9
  • [9] Complexity of the TOR signaling network
    Inoki, K
    Guan, KL
    [J]. TRENDS IN CELL BIOLOGY, 2006, 16 (04) : 206 - 212
  • [10] Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
    Jacinto, E
    Loewith, R
    Schmidt, A
    Lin, S
    Rüegg, MA
    Hall, A
    Hall, MN
    [J]. NATURE CELL BIOLOGY, 2004, 6 (11) : 1122 - U30